Undoubtedly, the recurrent nature of kidney stone disease is an important clinical and health economic problem. Despite the remarkable improvements in stone-removing technology in recent years, however, the risk of recurrence remains unchanged or even increased as a consequence of the residual fragments frequently encountered after all forms of low invasive treatment. Although patients with kidney stones need some form of standardized or individual metabolic and medical care to reduce their risk of forming further stones, insufficient attention is currently being paid to this aspect of patient management.
The focus on metabolic issues presented in the survey carried out by the authors of the article published in this issue entitled, "A Preliminary Survey of Practice Patterns across Several European Kidney Stone Centers and a Call for Action in Developing Shared Practice", is both appreciated and welcome. In this article, information on practice patterns is recorded from what the authors describe as a "stone centre belt" in Europe. Interestingly, most of these centres are under the direction of nephrologists. Of the 26 authors, 19 are based in nephrology units, 1 is a biochemist and only 6 are urologists. It is mentioned that recruitment to the survey is based on these authors' previous participation in consensus conferences, but further details regarding the criteria for the selection of the particular centres involved are not provided.
It is certainly praiseworthy that the authors make an attempt to take a firm grip of this heterogeneous and important field. Indeed, the future goal of stone management must be to establish a standardized scheme for risk-evaluation and treatment of patients with stone disease to identify why they have formed stones with a view to preventing them from experiencing further episodes of the disorder. To attain this goal, the authors claim not only that nephrologists are best suited for the management of these activities, but also that they should "take back" a primary role in this regard. This implies that, in future, the metabolic care of patients should not be the responsibility of urologists, but solely of nephrologists. Unfortunately, the authors fail to mention that globally relatively few nephrologists are interested in stone disease and accordingly only a select few may have the necessary expertise to take over the follow-up care of stone patients after the urologists have removed their stones.
Urolithiasis is a multi-factorial disorder that requires a multi-disciplinary approach to research into its cause(s) and management. Therefore, it seems unwise to put the management of stone patients solely under the control of one single section of the medical community. The "normal" progression of stone patients in many countries is for them to make an appointment with their family doctor who then refers them to a urologist who diagnoses and treats them in the most appropriate way to relieve their stone symptoms. In other countries, the patient may go straight to a urologist. Rarely, from our own experience in the UK and Sweden, is a nephrologist the patient's first port of call. Unfortunately, however, for many urologists in these countries, this is as far as their management of the patients goes other than to advise them "to drink more". A more enlightened approach employed by a small group of urologists is to investigate in detail why the patients have formed their stones and then institute some form of logical prophylactic treatment designed to prevent each individual patient from forming further stones based on the findings from these investigations which usually involve input from a number of colleagues including radiologists, clinical biochemists, nutritionists and, occasionally, nephrologists. Based on these findings, the urologist generally has the final say in the treatment programme, unless it is found that the patient requires specific medical treatment for some well-defined genetic or metabolic disorder that necessitates referral to a nephrologist or internal medicine clinician for onward, specialized treatment.
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Today, as mentioned above, the vast majority of patients with stone disease are first seen by urologists. In many urological stone centres, more than 20 patients are treated per week. The urologist is the natural first contact for these patients and although several specialities are necessary to deal with all aspects of the stone problem, the urologist is generally the person responsible for coordinating the different efforts. It is unfortunate, therefore, if urologists reading this article may get the impression that the metabolic and medical aspects of stone patients should only be handled by nephrologists or occasionally by those few urologists with specialized interests in the cause and preventative treatment of each patient's stones. On the contrary, given the large number of patients involved, we believe that all urologists should be strongly encouraged to take an increased interest in and responsibility for the medical and metabolic aspects associated with stone disease. This conclusion is based on the long-term clinical experience that, unless for very special circumstances, most patients are reluctant to have to consult several doctors or centres for the same disease. We believe, therefore, that one of the goals of the extensive project presented in this article should be to educate urologists what to do-when, why and how-rather than necessarily to refer them on to their local nephrologists who may or may not have a particular interest in urolithiasis.
Having said this, we strongly support the planned largescale network studies proposed by the authors. Such studies-if successfully completed-will yield valuable clinical information for the future management of patients with urolithiasis. However, it is necessary to add a note of caution, given the large number of patients involved, that treatment needs to be managed and followed up over periods of at least 5-7 years to yield meaningful data. Secondly, it should be agreed from the outset what particular investigations (blood, spot urine, 24-h urine or other timed urine, diet history, medical history, lifestyle pattern, etc.) should be carried out and which analytes and details from these tests should be recorded by all the participating centres. Thirdly, based on our experience, one fundamental pre-requisite for success and for avoiding confusion is that only SI units should be used in the analytical reports and for input into any future international databases. Indeed, Urolithiasis insists on this as one of the requirements for publication in our journal.
We wish the authors good fortune in the further development of this extensive study and look forward to learning about the results. But if the ultimate goal is to transfer all metabolic and medical care of these patients from urologists to nephrologists, in the light of the obvious lack of resources and general interest in urolithiasis among nephrologists as a whole, such a step might involve the risk of doing the patients a disservice. Whatever the approach finally agreed by the authors, the eventual solution to the problem of the management of stone patients after removal of their stones will require a change in the attitude of both nephrologists and urologists, in general, regarding their obligation to carry out the necessary investigations into the cause of a given patient's stone episode and the consequent development of his/her logical preventative therapy. This is the challenge facing the stone community worldwide.
